Clinical outcomes of abiraterone acetate + prednisone (AA) + bone resorption inhibitors (BRI) versus AA alone as first-line therapy for castration-resistant prostate cancer (CRPC) with bone metastases ...

A case study published in Topics in Companion Animal Medicine details the first report of hormone restoration therapy applied to a dog suffering from diverse physical and psychological symptoms ...

Smoking history and disease outcomes in patients with malignant germ cell tumors. A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) patients: Updated phase I ...

Injectable luteinizing hormone–releasing hormone agonists (e.g., leuprolide) are the standard agents for achieving androgen deprivation for prostate cancer despite the initial testosterone surge and ...

Image: UnsplashA Melbourne startup is developing a new wearable device, in partnership with the University of Melbourne and ...

Rugiet offers personalized, clinician‑led testosterone and hormone treatments for men, including enclomiphene and TRT. Here’s how it works.